PERTcast

With support from our colleagues at Thrombolex, this session provides an overview of pharmaco-mechanical thrombolysis and what the data tell us

Our faculty perform a mock PERT call with an intermediate high risk PE patient.

Join expert faculty as they describe the ins and outs of starting a PERT program

Learn more about how artificial intelligence may improve PE care

Hear firsthand from leaders of the Interhospital Transfer Project Dr. Charles Ross, Dr. Michael McDaniel, Dr. Belinda Rivera-Lebron, and Dr. Parth Rali who recap some of the key take aways from studying interhospital transfers of PE patients from across the country.

The Course Directors of The PERT Consortium's 2021 Annual Scientific Symposium summarize some key take aways from the event.

Speakers Dr. Thomas Tu, Dr. Andrew Klein, Dr. Wissam Jabber, Dr. Ken Rosenfield, Dr. Rachel Rosovsky, Dr. Victor Tapson, and Dr. Catalin Toma highlight the need for randomized controlled trials on treatment of intermediate-high risk pulmonary embolism.

The session features Dr. John Moriarty, Dr. Jaafar Golzar, and Dr. Brent Keeling who provide an overview of the AlphaVac System and provide an introduction to the APEX-AV study.

In this edition of PERTCast, Dr. Lindsay Lief, Professor Fionnuala Ní Áinle, and Professor Beverley Hunt recap important parts of the webinar: sex-specific differences in men and women as it relates to PE-specific events,  anticoagulation in women with menstrual periods, and PE diagnosis and treatment during pregnancy.

Listen in as Dr. Terry Bowers, Dr. Ken Rosenfield, and Dr. Eleni Whatley discuss findings from the inaugural PERC meeting.

Join Dr. Frances Mae West, Dr. Charles Grodzin, Dr. Emily Gundert, Dr. Jim Horowitz, & Dr. Alison Witkin as they recap mechanical measures to achieve hemodynamic stability, including ecmo and right ventricular support.

Dr. Jim Horowitz follows up with our speakers Dr. Brent Keeling, Dr. Rich Channick, Dr. Hillary Johnson-Cox, Dr. Sameer Khandar, and Dr. Akhilesh Sista to recap thoughts on burning questions like is clot burden associated with PE severity? Is increased clot removal associated with improved outcomes? Does increased retained clot lead to worsening long-term quality of life or outcomes?

Join us for this PERTcast featuring Dr. Ken Rosenfield, MD co-principal investigator in the latest clinical trial to date, Hi PEITHO. We meet the co-PI and ask clinical questions, trial endpoints, and study design for this new trial. Its a landmark venture you don't want to miss out on.

The PERT consortium invites you to listen to a podcast moderated by Geoff Barnes, MD, and joined by Rachel Rosovsky, MD, and Scott Kaatz, DO, as they discuss extended VTE treatment and the American Society of Hematology (ASH) 2020 guidelines. These podcasts were developed by the featured Pulmonary Embolism Response Team (PERT) Consortium speakers through a sponsorship from Janssen Pharmaceuticals,...

Debrief: EndoWars: Aspirate vs. Dissolve. If you missed the webinar, do not worry. James Horowitz, MD follows up with our speakers and moderator Geoff Barnes, MD, MSc, Carin Gonsalves, MD, FSIR, Jay Giri, MD, MPH, Maya Serhal, MD, and Keith Sterling, MD, FSIR.

Debrief from the PERT Webinar: Cancer and PE: A Growing Problem. If you missed the webinar, do not worry. Jim Horowitz, MD followed-up with our moderator - Rachel Rosovsky, MD, MPH and speakers - Marc Carrier, MD, Lisa Baumann Kreuziger, MD, MS, Alok A. Khorana, MD, FACP, FASCO and Tzu-Fei Wang, MD.

The PERT Consortium® kindly invites you to the webinar "Cancer and PE: A Growing Problem". Patients with cancer are at increased risk of developing pulmonary emboli. Join us to hear from world leading experts in cancer and thrombosis on the prevention, treatment, and adverse events that affect this vulnerable population. Our speakers are Marc Carrier, MD, Lisa Baumann Kreuziger, MD, MS, Alok A. Kh...

CTEPH, the rare yet increasing complication of pulmonary embolism. We discuss the surgical management of CTEPH, when to refer, evaluation timeline, and key points which you should not miss. Dr. Jon Haft, MD, is an Associate Professor of Cardiothoracic Surgery at University of Michigan Medical Center.

The PERT Consortium invites you to listen to a podcast moderated by Victor Tapson, MD, and joined by Alex Spyropoulos, MD, and Greg Piazza, MD, as they discuss the VTE risk for hospitalized acutely ill medical patients, risk stratification tools, and the population health impact. These podcasts were developed by the featured Pulmonary Embolism Response Team (PERT) Consortium speakers through a spo...

Patient PERTspective: 8 Time Jeopardy Champion Jennifer Quail didn't let her new diagnosis of pulmonary embolism and antiphospholipid syndrome stop her from competing in the tournament of champions. Her impressive comeback from a serious medical condition.

Debrief: Home management of PE. If you missed the webinar, do not worry. We spoke with Rachel Rosovsky, President Elect, Hematologist at Massachusetts General Hospital on home management of VTE, appropriate patient selection, and role for follow up once discharged.

The PERT Consortium® kindly invites you to listen to the audio from our webinar entitled, "Endo Wars: Aspirate vs. Dissolve" .   Experts will debate the optimal management for two patients with intermediate-high risk pulmonary embolism. In these two debates, we will explore the evidence and practice patterns supporting the use of anticoagulation alone vs. catheter-directed therapies. We will also...

Episode 8: Our guest, Dr. Robert Lookstein, MD, MHCDL is a Professor of Radiology and Surgery at Mt Sinai as well as the Executive Vice Chairman of Radiology and the current President of the PERT Consortium. #PERTprez speaks!    

Episode 7: Our guest, John Moriarty MD FSIR is an interventional radiologist and an Associate Professor at UCLA with appointments in both the Departments of Radiology and Internal Medicine. James Horowitz MD FACC FAHA is a cardiac intensivist and is the director of the Cardiac ICU and NYU Langone Health.  Links:  Endovascular Removal of Thrombus and Right Heart Masses Using the AngioVac System: Re...